2026. AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability. Explore Medical Science and Global Health. 3, (Oct. 2026), 38–47. DOI:https://doi.org/10.70267/emsgh.v3.3847.